Cytomegalovirus infection in kidney transplantation: prophylaxis and management.
Bulinski
P
P
Michigan Transplant Institute, Borgess Medical Center, Kalamazoo, USA.
Toledo-Pereyra
L H
LH
Dalal
S
S
Hernandez
G
G
D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D005500:Follow-Up Studies; D015774:Ganciclovir / Q000627:therapeutic use*; D006085:Graft Survival; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology; D016133:Polymerase Chain Reaction; D011183:Postoperative Complications; D012189:Retrospective Studies
D000914:Antibodies, Viral; D000998:Antiviral Agents; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D015774:Ganciclovir